Home > Insider Trading > Filing (0000939767-25-000077)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
939767	Exelixis Inc.	EXEL	Biological Products, (No Disgnostic Substances) (2836)	043257395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1692954	J. Patrick Haley	C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502	Evp, Commercial	No	Yes	No	No

Transaction Summary

Sold:	136,383 shares	Avg. Price: $47.58	Total Value: $6,488,503.15
Number of Shares After Transactions:	446,459 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2025-05-14	10,000	$42.68	491,164	No	4	S	Direct
Common Stock	Disposition	2025-05-15	34,705	$44.65	456,459	No	4	F	Direct
Common Stock	Disposition	2025-05-15	10,000	$46.95	446,459	No	4	S	Direct
Common Stock	Acquisiton	2025-05-15	116,383	$18.80	562,842	No	4	M	Direct
Common Stock	Disposition	2025-05-15	116,383	$48.05	446,459	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Disposition	2025-05-15	116,383	$0.00	116,383	$18.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2019-09-10	2025-09-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	23,539	Indirect	By spouse
Common Stock	10,648	Indirect	By 401(k)

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024.
Includes 374,029 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-basedrestricted stock units ("PSUs") and 753 shares of Common Stock acquired on April 30, 2025, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Each RSU is the economic equivalent ofone share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.
Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of RSUs awarded on March 4, 2021, March 4, 2022, April 3, 2023, and February 23, 2024.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $48.05 to $48.16. Reporting Person undertakes to provide Exelixis, Inc., any securityholder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth infootnote 4 to this Form 4.
Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2025.
The option, representing the right to purchase a total of 116,383 shares of Common Stock, became fully exercisable on September 10, 2022.